Impact Biomedical (IBO) Receivables (2023 - 2025)

Impact Biomedical (IBO) posted Receivables of $5000.0 for Q4 2025, down 97.49% on a QoQ basis from $199000.0 in Q3 2025, and down 97.51% year-over-year from $201000.0 in Q4 2024.

Impact Biomedical (IBO) Receivables (2023 - 2025) Analysis & Trends

Impact Biomedical's Receivables history runs 3 years deep, the most recent figure standing at $5000.0 for Q4 2025.

  • Quarterly Receivables fell 97.51% year-over-year to $5000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5000.0 (down 97.51% YoY) and the FY2025 annual result came in at $5000.0, down 93.15% from the prior year.
  • Receivables was $5000.0 for Q4 2025 at Impact Biomedical, down from $199000.0 in the prior quarter.
  • Across five years, Receivables topped out at $201000.0 in Q4 2024 and bottomed at $5000.0 in Q4 2025.
  • A 3-year average of $148625.0 and a median of $163500.0 in 2023 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2024 — Receivables soared 57.03% — and 2025, when it sank 97.51%.
  • Impact Biomedical's Receivables stood at $128000.0 in 2023, then surged by 57.03% to $201000.0 in 2024, then sank by 97.51% to $5000.0 in 2025.
  • Business Quant data shows IBO's Receivables at $5000.0 in Q4 2025, $199000.0 in Q3 2025, and $200000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Impact Biomedical 47.44 Mn 50.67 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 5,000.00
Sep 30, 2025 199,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 201,000.00
Jun 30, 2024 128,000.00
Mar 31, 2024 128,000.00
Dec 31, 2023 128,000.00